OxyElite Pro Lawsuits

Potential side effects of OxyElite Pro, a weight loss and body building dietary supplement, have been linked to an outbreak of cases involving acute hepatitis and liver damage in late 2013.

OXYELITE PRO LAWSUIT STATUS: As the investigation into the exact cause of the liver problems continues, product liability lawyers are reviewing potential OxyElite Pro injury lawsuits for former users diagnosed with acute hepatitis, acute liver damage or liver failure, which may lead to the need for a liver transplant.

>>SUBMIT INFO ABOUT OXYELITE PRO LIVER INJURY<<

Did You Know?

Ticketmaster Data Breach Impacts Millions of Customers

A massive Ticketmaster data breach exposed the names, addresses, phone numbers, credit card numbers and other personal information of more than 560 million customers, which have now been released on the dark web. Lawsuits are being pursued to obtain financial compensation.

MANUFACTURER: USPLabs

OVERVIEW OF OXYELITE PRO LIVER PROBLEMS: OxyElite Pro is a Yohimbe-based weight loss and body building supplement sold by USPLabs. In the second half of 2013, the product was linked to a large number of reports involving acute hepatitis and liver damage, primarily identified in Hawaii, and was eventually recalled.

The first cases of OxyElite Pro liver problems was discovered in April 2013. After seven cases were reported by September 2013, state and federal health agencies investigated and found more than 45 potential cases, including at least one death, two cases that resulted in liver transplants and 27 confirmed cases of acute hepatitis or liver damage.

On October 8, the FDA issued a public health warning about the possible risk of liver problems from OxyElite Pro.

The FDA investigated the cause of the liver damage and determined that it was the most likely source of the outbreak and likely an adulterated product, but no reason has been given for why OxyElite Pro may be causing liver injury. Also, only a few cases have been linked to consumers outside of Hawaii as of mid-October 2013, and one of those cases was a Hawaiian who bought OxyElite Pro in Hawaii but was diagnosed in another state.

As of September 2014, more than 40 plaintiffs had filed lawsuits claiming to have suffered liver-related illnesses after using either OxyElite Pro or a similar USPLabs product, Jack3d.

OXYELITE RECALL: On November 10, 2013, USPLabs announced an OxyElite Pro recall was being issued for all lots and sizes of the dietary supplement. The action came after the FDA sent a letter warning that the federal health regulators could force the product off shelves if a voluntary recall was not issued.

Prior to the official the recall of OxyElite Pro, the Hawaii Department of Health has already asked stores to remove OxyElite Pro from shelves. All eventually did so and the agency embargoed further shipments of the dietary supplement to Hawaii.

0 Comments

Share Your Story With Our Community

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Change Healthcare Data Breach Lawyers Meeting Today With MDL Judge For Initial Status Conference
Change Healthcare Data Breach Lawyers Meeting Today With MDL Judge For Initial Status Conference (Posted yesterday)

The judge presiding over all Change Healthcare lawsuits filed in federal court is holding the first status conference of the litigation, which is expected to grow significantly as Change Healthcare data breach letters continue to be sent to impacted customers.

Angiodynamics LifePort Lawsuit Filed Over Risk of the Port Catheters Failing, Causing Severe Injury
Angiodynamics LifePort Lawsuit Filed Over Risk of the Port Catheters Failing, Causing Severe Injury (Posted 2 days ago)

Complaint comes as a panel of federal judges are scheduled to hear oral arguments later this month, to determine whether all AngioDynamics port catheter lawsuits filed in U.S. District Courts nationwide should be centralized before one judge.